AAT 39.00 American Assets Trust $AAT Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
AAT 39.00 American Assets Trust $AAT Hit a 52 week high of 39.24 Closing the day 09:44 at 39.00 -0.04 -0.10% With a day low of 38.86 and a total volume of 7,292.

AAT Recent Posts: http://investorshangout.com/American-Assets-Trust-AAT-49963/

AAT American Assets Trust Recent Headline News

American Assets Trust's (AAT) CEO John Chamberlain on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 2:27AM CST

AAT: 38.95 (-0.09)

American Assets (AAT) Showing Signs Of Being Strong And Under The Radar
at The Street - Wed Nov 05, 9:04AM CST
Trade-Ideas LLC identified American Assets (AAT) as a strong and under the radar candidate
AAT: 38.95 (-0.09)

American Assets Trust reports 3Q results
Automated Insights - Wed Nov 05, 4:03AM CST
SAN DIEGO (AP) _ American Assets Trust Inc. (AAT) on Wednesday reported a key measure of profitability in its third quarter. The results beat Wall Street expectations.
AAT: 38.95 (-0.09)

American Assets Trust, Inc. Reports Third Quarter 2014 Financial Results
Thomson Reuters ONE - Tue Nov 04, 3:05PM CST

AAT: 38.95 (-0.09)

American Assets Trust, Inc. Announces Issuance of $150 Million of 4.04% Senior Guaranteed Notes, Series A, Due October 31, 2021
Thomson Reuters ONE - Fri Oct 31, 3:05PM CDT
Company Release - 10/31/14
AAT: 38.95 (-0.09)

American Assets Trust Breaks Below 200-Day Moving Average - Notable for AAT
MarketNewsVideo.com - Wed Oct 08, 10:22AM CDT
In trading on Wednesday, shares of American Assets Trust, Inc. crossed below their 200 day moving average of $33.75, changing hands as low as $33.74 per share.
AAT: 38.95 (-0.09)

American Assets Trust, Inc. Announces Third Quarter 2014 Earnings Release Date and Conference Call Information
Thomson Reuters ONE - Fri Oct 03, 6:04PM CDT
American Assets Trust, Inc. Announces Third Quarter 2014 Earnings Release Date and Conference Call Information
AAT: 38.95 (-0.09)

Strong And Under The Radar Today: American Assets (AAT)
at The Street - Wed Sep 03, 9:00AM CDT
Trade-Ideas LLC identified American Assets (AAT) as a strong and under the radar candidate
AAT: 38.95 (-0.09)

American Assets Trust, Inc. Reports Second Quarter 2014 Financial Results
Thomson Reuters ONE - Tue Jul 29, 3:06PM CDT

AAT: 38.95 (-0.09)

American Assets Trust, Inc. Announces Second Quarter 2014 Earnings Release Date and Conference Call Information
Thomson Reuters ONE - Mon Jul 07, 12:49PM CDT
Company Release - 7/7/14
AAT: 38.95 (-0.09)

Form 4: Update Filing for Chemung Financial Corp (CHMG)
Vickers Stock Research - Wed Feb 19, 5:18AM CST
Company Release - 2/19/13
AAT: 38.95 (-0.09), CHMG: 28.27 (+0.06)

American Assets Trust, Inc. Announces Fourth Quarter and Year-End 2013 Earnings Release Date and Conference Call Information
Thomson Reuters ONE - Fri Jan 10, 1:01PM CST

AAT: 38.95 (-0.09)

American Assets Trust, Inc. Unveils Vision and Name for Lloyd District Project
Thomson Reuters ONE - Tue Sep 17, 4:17PM CDT
American Assets Trust, Inc. Unveils Vision and Name for Lloyd District Project
AAT: 38.95 (-0.09)

American Assets Trust, Inc. to Unveil Vision and Name for Lloyd District Project
Thomson Reuters ONE - Fri Sep 13, 4:27PM CDT
- New development for Lloyd District will transform the neighborhood, adding over 600 new residences and dozens of local businesses -
AAT: 38.95 (-0.09)

Plum Creek Pinned at Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 23, 5:25PM CDT
On Aug 22, 2013, we reiterated our long-term Neutral recommendation on Plum Creek.
AAT: 38.95 (-0.09), RPT: 17.57 (+0.11), PCL: 40.87 (+0.07), GRT: 13.85 (+0.04)

American Assets Trust, Inc Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 22, 1:46AM CDT
American Assets Trust, Inc Enters Oversold Territory
AAT: 38.95 (-0.09)

American Assets Trust, Inc. To Host Investor Day in Portland, Oregon
Thomson Reuters ONE - Thu Aug 15, 11:40AM CDT
Company Release - 8/15/13
AAT: 38.95 (-0.09)

Acquisitions, Divestitures, New Lease Agreements, and Conference Call Schedules - Research Report on Digital Realty, Mack-Cali, CBL & Associates, CapLease, and American Assets Trust
PR Newswire - Thu Jul 18, 7:00AM CDT
Today, Investors' Reports announced new research reports highlighting Digital Realty Trust Inc. (NYSE: DLR), Mack-Cali Realty Corp. (NYSE: CLI), CBL & Associates Properties Inc. (NYSE: CBL), CapLease, Inc. (NYSE: LSE), and American Assets Trust, Inc. (NYSE: AAT). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
AAT: 38.95 (-0.09), DLR: 68.73 (+0.33), CBL: 18.85 (+0.08), CLI: 19.47 (+0.04)

Neutral on Taubman Centers - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 12, 8:50AM CDT
On Jul 11, 2013, we reiterated our long-term recommendation on Taubman Centers Inc. at Neutral.
AAT: 38.95 (-0.09), SPG: 179.10 (+0.78), MAC: 68.95 (+0.35), TCO: 76.60 (+0.28)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 304

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Sintilimab Poised for New Milestone in Melanoma Fight

Updated Category News Views 39

An Opening Shot: NMPA's Decision Window Well, here's the latest chapter in the saga of battling advanced melanoma with some real gritty numbers behind it. Innovent Biologics has thrown its hat back in the ring with news that the China National Medical Products Administration (NMPA) has embraced a new indication application for their drug sintilimab. They're teaming it up...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 421

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 212

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 0

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 264

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 264

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Dar Global Eyes Dubai for Strategic Real Estate Moves

Updated Category News Views 0

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

Continue Reading

Top 5 Most Recently Viewed Articles

Dandy® Celery Innovates Back-to-School Snacking Options

Updated Category News Views 53

Dandy® Celery Offers Innovative Snacking for Back-to-School Dandy® Produce, a leading name in fresh celery, is here to support families as they navigate back-to-school routines. They provide a variety of quick and healthy meal and snack options. Their fresh-cut celery sticks are a perfect addition to school lunches, afterschool snacks, and even quick sides for busy...

Continue Reading
General Dynamics (GD): Navigating Aerospace Headwinds and Opportunities

Updated Category News Views 209

General Dynamics: Current Market Dynamics General Dynamics Corporation (NYSE: GD) is widely recognized for its pivotal role in the aerospace and defense sectors. The company has a strong reputation, particularly for producing Gulfstream jets, alongside its diverse range of military and marine systems. Despite its established position, General Dynamics has been...

Continue Reading
SunCar Technology Group Inc. Enters NASDAQ Golden Dragon Index

Updated Category News Views 74

SunCar Technology Group Inc. Achieves Milestone Inclusion SunCar Technology Group Inc. (NASDAQ: SDA), a prominent player in the cloud-based B2B automotive services and insurance sector, proudly announces its recent addition to the NASDAQ Golden Dragon China Index. This significant achievement illustrates the company's upward journey and strengthens its market positioning....

Continue Reading
Strategic Investment by BrainsWay to Enhance Mental Health Solutions

Updated Category News Views 165

BrainsWay's Expansion Plans and Strategic Investment This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home. Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. FDA, and if granted, it will set a precedent as the first FDA-cleared medical...

Continue Reading
Future Projections: Cosmetic Surgery Market Growth Insights

Updated Category News Views 97

The Expanding Cosmetic Surgery Market The cosmetic surgery market is anticipated to experience significant growth over the coming years, with projections indicating an increase from USD 56.98 billion in 2024 to approximately USD 83.34 billion by 2034. This impressive growth represents a compound annual growth rate (CAGR) of 3.84% from 2024 to 2034, driven by a variety of...

Continue Reading